Both IL-1β and IL-18 exert pro-inflammatory effects through the nuclear factor kappa-light-chain-enhancer of activated β cells (NF-κβ) pathway and are involved in the atherosclerosis process [20, 21]. Here, IL18 is linked to atherosclerosis.